-
-
-
-
-
-
-
iBio reports fat reduction in primate study of obesity drug candidate
-
-
-
-
-
-
-
iBio, Inc. (IBIO) PT Lowered to $1.60 at Brookline Capital Markets
-
-
-
-
-
-
-
iBio, Inc. (IBIO) Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth
-
-
-
-
416,812 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

